Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biochem Soc Trans. 2010 Aug;38(4):993-5. doi: 10.1042/BST0380993.

Pathways linking Abeta and tau pathologies.

Author information

  • Department of Neurobiology and Behavior and Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, CA 92697, USA. laferla@uci.edu

Abstract

Abeta (amyloid beta-peptide) and tau are the main proteins that misfold and accumulate in amyloid plaques and NFTs (neurofibrillary tangles) of Alzheimer's disease and other neurological disorders. Historically, because plaques and NFTs accumulate in diverse cellular compartments, i.e. mainly extracellularly for plaques and intracellularly for NFTs, it was long presumed that the constituent proteins formed these lesions via unrelated pathways. Animal and cell studies over the last decade, however, have provided convincing evidence to show that Abeta can facilitate the development of tau pathology by altering several cell-dependent and -independent mechanisms. In the present article, results are reviewed from several laboratories that show that modulating Abeta pathology can directly affect the development of tau pathology, which has significant implications for the treatment of Alzheimer's disease.

PMID:
20658991
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Portland Press
    Loading ...
    Write to the Help Desk